Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MEDI-551 |
Trade Name | Uplizna |
Synonyms | Inebilizumab|MEDI551|MEDI 551 |
Drug Descriptions |
MEDI-551 (Inebilizumab) is a monoclonal antibody directed against CD19, which binds CD19 and enhances antibody-dependent cytotoxic immune response against CD19-positive B-cells (PMID: 20605905). |
DrugClasses | CD19 Antibody 21 |
CAS Registry Number | 1299440-37-1 |
NCIT ID | C88283 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MEDI-551 | MEDI-551 | 0 | 1 |